Last updated: February 16, 2026
Glycyrrhizin, a triterpenoid saponin derived from licorice root, is used primarily for its anti-inflammatory, antiviral, and hepatoprotective properties. Its role in pharmaceutical and nutraceutical sectors influences market demand dynamics. The compound’s revenue streams stem from both direct extraction and synthesized derivatives used in pharmaceutical formulations.
What Are the Key Market Drivers for Glycyrrhizin?
-
Increased Demand in Herbal Medicines: Glycyrrhizin’s use in traditional and modern herbal remedies fuels growth. The global herbal medicine market expanded at a CAGR of 6.2% from 2018 to 2022, with licorice-derived compounds contributing significantly.
-
Focus on Liver Disease Treatments: Rising prevalence of hepatitis B and C, fatty liver disease, and other hepatic conditions increases demand for hepatoprotective agents such as glycyrrhizin. Globally, the hepatitis drugs market reached $20.1 billion in 2022, with natural products gaining traction.
-
Development of Anti-Viral Therapies: Glycyrrhizin exhibits anti-viral activities against SARS-CoV-2 and other viruses. The COVID-19 pandemic spurred research and investment into plant-based antivirals, impacting glycyrrhizin’s market development.
-
Food and Nutraceutical Applications: Growing consumer interest in natural flavors, sweeteners, and health supplements supports glycyrrhizin usage, especially as a natural sweetener with lower caloric content.
What Factors Might Limit Market Growth?
-
Regulatory Challenges: Variability in regulatory approval processes across regions hampers commercialization. Glycyrrhizin faces different safety and efficacy standards in the US (FDA), Europe (EMA), and Asia (CFDA).
-
Supply Chain Constraints: Dependence on licorice crop cultivation exposes the market to agricultural risks such as climate variability, pests, and geopolitical issues affecting supply stability.
-
Safety and Toxicity Concerns: Long-term consumption of high doses of glycyrrhizin can induce adverse effects such as hypertension, hypokalemia, and edema, which restrict dosage and applications.
Market Size and Revenue Breakdown
| Segment |
Estimated Market Size (2022) |
Projected CAGR (2023–2028) |
Key Applications |
| Pharmaceutical (Hepatoprotective) |
$120 million |
5.5% |
Hepatitis treatment, anti-inflammatory drugs |
| Food & Nutraceuticals |
$80 million |
7% |
Natural sweeteners, dietary supplements |
| Cosmetics & Personal Care |
$30 million |
4.8% |
Skin soothing products |
The global glycyrrhizin market was valued at approximately $230 million in 2022. It is expected to grow to $340 million by 2028, reflecting a compound annual growth rate of approximately 6.2%.
Regional Market Insights
-
Asia-Pacific: The dominant region, accounting for roughly 55% of market revenue, driven by large-scale licorice cultivation in China, India, and Korea. Regional regulatory acceptance and traditional medicine practices influence volume.
-
Europe: Focuses on pharmaceutical applications, with a regulatory environment favoring natural compounds. European market growth hinges on research and development collaborations.
-
North America: Growth driven by increasing interest in plant-based therapeutics and supplement markets. Stringent safety regulations shape product development.
Financial Trajectory and Investment Outlook
Revenue Trajectory
| Year |
Estimated Market Size |
Increase from 2022 |
Notable Drivers |
| 2023 |
$245 million |
6.5% |
Launch of new herbal remedies, COVID-19 antiviral research |
| 2024 |
$260 million |
13% (from 2022) |
Expansion in nutraceutical offerings, new regulatory approvals |
| 2025 |
$280 million |
21.7% |
Broadened pharmaceutical pipelines, supply chain stabilization |
| 2026 |
$310 million |
34.8% |
Increased adoption in cosmeceuticals, further clinical validations |
| 2028 |
$340 million |
41.3% |
Mature market with new formulations, expanded global regulation |
Key Investment Factors
-
R&D Focus: Investment in derivatives with improved bioavailability or reduced toxicity enhances market potential. Partnerships with biotech firms support innovation.
-
Supply Chain Development: Vertical integration in licorice cultivation and extraction can mitigate risks.
-
Regulatory Strategy: Navigating and harmonizing approvals across regions increases market access.
-
Market Penetration: Diversification into cosmetic and food industries broadens revenue streams.
Competitive Landscape
Leading players include:
- Standard Licorice Co.
- NutraPharm Inc.
- PharmaBio Solutions
- Bioray Japan
Market entry often involves licensing agreements, joint ventures, or acquisitions to access raw materials and distribution channels.
Key Considerations for Stakeholders
-
Intellectual Property: Patents around glycyrrhizin extraction methods, derivatives, and formulations enhance competitive advantage.
-
Sustainability: Cultivation practices influencing licorice crop yields impact pricing and supply reliability.
-
Regulatory Pathways: Emphasis on clinical trials and safety data to accelerate approval processes.
Key Takeaways
-
The glycyrrhizin market is constrained by regulatory variances and supply chain risks but grows with increased applications in pharmaceuticals, nutraceuticals, and cosmetics.
-
Estimated market size was $230 million in 2022, with projections reaching $340 million by 2028 at a compound annual growth rate of over 6%.
-
Asia-Pacific dominates regional sales, with emerging markets in North America and Europe expanding due to consumer health trends and product innovation.
-
The market's financial trajectory shows steady growth with potential for acceleration through new derivatives, improved extraction techniques, and regulatory clearances.
FAQs
-
What is the primary medical application of glycyrrhizin?
It is mainly used for liver protection, particularly in treating hepatitis B and C, and as an anti-inflammatory agent.
-
How does regulation affect glycyrrhizin commercialization?
Different approval standards and safety requirements across jurisdictions may delay market entry or restrict usage levels.
-
What major factors influence supply stability for glycyrrhizin?
Cultivation conditions, climate change, pest infestations, and geopolitical issues impact licorice crop yields.
-
Are there concerns about the safety of glycyrrhizin?
Yes, high doses can lead to hypertension and hypokalemia; safety limits influence product development.
-
What innovations could expand the market for glycyrrhizin?
Developing derivatives with enhanced bioavailability, reducing toxicity, and creating new delivery systems.
Sources:
[1] MarketsandMarkets, "Herbal Medicine Market," 2022.
[2] Grand View Research, "Natural Anti-inflammatory Drugs," 2023.
[3] Allied Market Research, "Plant-Based Extracts," 2023.
